Patrick Lin
Chief Business - Strategy Off · Processa Pharmaceuticals, Inc.
- 2025
- Jul 29, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Patrick Lin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Russell Skibsted - $42K in PCSA purchases and sales in the last 12 months
- George K. Ng - $39K in PCSA purchases and sales in the last 12 months
- Wendy Guy - $33K in PCSA purchases and sales in the last 12 months
- David Young - $32K in PCSA purchases and sales in the last 12 months
- Sian Bigora - $21K in PCSA purchases and sales in the last 12 months
- Khoso Baluch - $6K in PCSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Patrick Lin?
Patrick Lin is a corporate insider, tracked as Chief Business - Strategy Off of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Patrick Lin last file a Form 4?
The most recent primary Form 4 on record is dated 29 July 2026, one of 11 filings going back to 2025.
Has Patrick Lin been buying or selling stock?
Recorded transactions: 7 open-market purchases ($28K) and 0 open-market sales across all tracked filings.
